Lundbeck CEO puts 6M crowns into company stock; Pfizer to sell off 4 products for Hospira deal nod;

@FiercePharma: ICYMI Friday: Novartis shells out up to $1B to test GSK's Arzerra in MS. Item | Follow @FiercePharma

@EricPFierce: Email exchange with Merck CEO posted by union shows frustrations over job cuts, double shifts. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Novartis places $1B bet to push CLL med Arzerra into MS fray. FiercePharmaMarketing story | Follow @CarlyHFierce

> Lundbeck CEO Kåre Schultz, in a vote of confidence in his recently announced restructuring plans for the company, ploughed almost 6 million Danish crowns, or about $904,000, into Lundbeck shares. Report

> Pfizer ($PFE) won U.S. approval for its big Hospira ($HSP) buyout, provided it sells off four sterile injectable drugs; the company has already promised to divest some drug rights to win EU approval. Report

> The European Commission gave the green light to Perrigo's ($PRGO) proposed deal to buy a range of products from GlaxoSmithKline ($GSK). Report

> Partnerships with Big Pharma firms are helping to drive growth at Korea's drugmakers, including Hanmi Pharmaceuticals, which recently inked a licensing deal with Boehringer Ingelheim. Report

> Merck KGaA plans to shut down Bangalore GeNei, an Indian company it bought in 2009. Report

> India's Glenmark Pharmaceuticals rolled out a new diabetes drug to compete with Big Pharma's DPP-4 meds. Report

Medical Device News

@FierceMedDev: DARPA-backed Wyss Institute sepsis device being readied for human trials. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDrugDelivery: Edge files for up to $115M IPO to support locally delivered med for brain aneurysms. Report | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Olympus duodenoscopes linked to suspected superbug outbreak at California hospital. More | Follow @EmilyWFierce

> Bayer's Grants4Apps accelerator funds its second crop of digital health startups. Story

> Micro-cap TriVascular starts post-market registry trial as it raises $10M. Article

Biotech News

@FierceBiotech: ICYMI Friday: Takeda rolls toward EU approval with its heir to Velcade. Story | Follow @FierceBiotech

@JohnCFierce: AstraZeneca lures Bohen from Genentech to fill R&D post vacated by Morrison. Report | Follow @JohnCFierce

> BTD in hand, Exelixis speeds cabo application to FDA. More

> Vital Therapies' shares crash on news of a PhIII failure. Story

> Hatteras rounds up $90M to lead a biotech rebound in NC. Article

Animal Health News

> Report: Dietary supplements gaining popularity as aging dogs fight arthritis. Report

> Free of Zoetis, Sweden's Oasmia hits the road to pitch IPO. Article

> USDA solicits bids for bird flu vaccine production plan. Item

> Beef producers lash out at USDA's choice of Humane Society vet for advisory panel. Story

> Petco files for IPO, emphasizing focus on animal health. News

Biotech IT News

> Biogen taps ice bucket cash to build ALS database. More

> Life science unit graduates from Google X to become standalone business. News

> Intel makes pitch to become a hub for cancer data sharing. Report

> Flatiron teams with Guardant to mine blood test data for cancer R&D. Story

> Illumina teams with VCs to place $100M bet on consumer genomics. Article

Pharma Marketing News

> Janssen's new Prezcobix push urges HIV patients to share pics with their docs. Story

> Novartis places $1B bet to push CLL med Arzerra into MS fray. Report

> Medivation snaps up BioMarin's late-stage breast cancer med in $410M-plus deal. Item

> Sure, there's an app for that, but few top pharma apps get most of the attention. More

> Purdue hones abuse-deterrent edge with painkiller safety campaign. Article

And Finally... Major U.S. corporations are saving up to $3 trillion by shifting their retirees to private Obamacare exchanges. Report